In this digital transformation race sprung about by COVID-19, companies like IMAPAC have rapidly increased the use of digital tools to stay afloat during the pandemic. Revamping from having a portfolio that consisted… read more

INFOGRAPHIC OF THE WEEK In a recent market outlook analysis by Genetic Engineering & Biotechnology News, the APAC global cell and gene therapy space has been predicted to emerge as a major market.… read more

IMAPAC recently rounded up its “Corona360 In-Conversation” series of live moderated interviews. It brought together vaccine industry experts in lively, thought-provoking discussions on the challenges and possible solutions in the race to develop… read more

KM Biologics Announces Phase I Clinical Study Results of a Live Attenuated Tetravalent Dengue Vaccine (KD-382) KM Biologics Co., Ltd. (Headquarters: Kumamoto, Japan; CEO: Toshiaki Nagasato) announced the results of the Phase I… read more

AbbVie sells biologics plant to Pharmaron, fueling the China company's cell and gene therapy ambitions Roughly half a year after closing its $63 billion megamerger with Allergan, AbbVie is letting go of the… read more

UCI Health Creates New Delivery System For Monoclonal Antibodies In COVID-19 Patients Monoclonal antibodies are showing promise for improving outcomes for COVID-19 patients, but when a hospital is already beyond capacity, administering them… read more

WuXi Biologics to Acquire Pfizer China’s Biologics Manufacturing Facilities WuXi Biologics announced on March 17, 2021 that it has entered into an equity agreement with Pfizer China to acquire its biologics manufacturing facilities… read more

Matica Biotechnology, Inc. Announces Master Research Agreement with Texas A&M Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene… read more

TILT Biotherapeutics advances cancer immunotherapy clinical trial achieving primary end point in the first cohort TILT Biotherapeutics, a clinical-stage biotechnology company developing cancer immunotherapeutics, announces that it has achieved the primary endpoint of… read more

CARISMA Therapeutics Announces First Patient Dosed in Landmark Clinical Study Evaluating Engineered Macrophages in Humans CARISMA Therapeutics Inc., a clinical stage biopharmaceutical company spun out of the University of Pennsylvania (Penn) and focused on discovering… read more

CEPI and VBI Vaccines Collaborate to Advance Vaccine Candidates Against COVID-19 Variants CEPI, the Coalition for Epidemic Preparedness Innovations, and VBI Vaccines Inc. (Nasdaq: VBIV), today announced a partnership to develop VBI’s enveloped… read more

GSK makes landmark pricing agreement for rotavirus vaccine, Rotarix, for use with children living in humanitarian crises As announced today by WHO, Médecins Sans Frontières (MSF), Save the Children and UNICEF, GSK has… read more

More than 1.7 million COVID-19 vaccines arrive in the Democratic Republic of Congo More than 1.7 million doses of COVID-19 vaccines have arrived in Kinshasa, the capital of the DRC. They were shipped… read more